Reconsider Restrictions on Manufacturing of Oxytocin in India: IMA

The IMA has claimed that KAPL does not have the experience or the capacity to handle such a huge responsibility.

Stating the importance of life-saving drug oxytocin for young mothers and obstetricians, the Indian Medical Association (IMA) has demanded a reconsideration of the government's policy which prohibits the import of the drug, and restricts its manufacture for domestic use.

The Union Health Ministry had exclusively handed over the production of oxytocin to Karnataka Antibiotics and Pharmaceuticals Limited (KAPL) after reports of misuse of the drug in the dairy sector came to light.